Home
TSHA
TSHA News

Latest Taysha Gene Therapies Inc. (TSHA) News on May 11, 2025

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

GlobeNewswire

3 days ago

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

5 days ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?

Zacks

6 days ago

Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 days ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Discover Fractyl Health And 2 More Promising Penny Stocks

Simply Wall St.

19 days ago

Discover Fractyl Health And 2 More Promising Penny Stocks

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

a month ago

Biotech stocks slide as Marks resignation seen being negative for sector

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts?

Insider Monkey

2 months ago

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nano Dimension And 2 Other Penny Stocks To Watch Now

Simply Wall St.

2 months ago

Nano Dimension And 2 Other Penny Stocks To Watch Now

Taysha Gene Therapies Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

2 months ago

Taysha Gene Therapies Full Year 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

3 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

3 months ago

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

GlobeNewswire

3 months ago

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Scienjoy Holding Leads Our 3 US Penny Stocks To Consider

Simply Wall St.

3 months ago

Scienjoy Holding Leads Our 3 US Penny Stocks To Consider

Acelyrin Leads The Charge With 2 Other US Penny Stocks

Simply Wall St.

4 months ago

Acelyrin Leads The Charge With 2 Other US Penny Stocks

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

6 months ago

Q3 2024 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

GuruFocus.com

6 months ago

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Zacks

6 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

US Penny Stocks To Watch In November 2024

Simply Wall St.

6 months ago

US Penny Stocks To Watch In November 2024

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

GlobeNewswire

6 months ago

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

GlobeNewswire

7 months ago

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?

Insider Monkey

7 months ago

Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?

Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why

Zacks

7 months ago

Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?

Insider Monkey

7 months ago

Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress

GlobeNewswire

8 months ago

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress

Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?

Zacks

8 months ago

Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

9 months ago

Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates

Zacks

9 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates

Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has caught the attention of institutional investors who hold a sizeable 46% stake

Simply Wall St.

9 months ago

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has caught the attention of institutional investors who hold a sizeable 46% stake

Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12

GlobeNewswire

9 months ago

Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Argus Research

10 months ago

Daily – Vickers Top Buyers & Sellers for 07/02/2024

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

Simply Wall St.

10 months ago

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

MT Newswires

10 months ago

Taysha Gene Therapies Insider Bought Shares Worth $2,999,999, According to a Recent SEC Filing

MT Newswires

10 months ago

BMO Initiates Taysha Gene Therapies at Outperform With $5 Price Target

MT Newswires

a year ago

Taysha Gene Therapies Prices $75 Million Offering of Shares, Pre-Funded Warrants; Shares Fall

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

MT Newswires

a year ago

Top Premarket Decliners

MT Newswires

a year ago

Taysha Gene Therapies Starts $75 Million Common Stock Offering

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

BioPharma Dive

a year ago

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

GlobeNewswire

a year ago

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

CNW Group

a year ago

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

Motley Fool

a year ago

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

3 Capital Markets Stocks to Buy Hand Over Fist in June

Motley Fool

a year ago

3 Capital Markets Stocks to Buy Hand Over Fist in June

3 Types of Homes To Buy During Summer 2024 To Get Rich

GOBankingRates

a year ago

3 Types of Homes To Buy During Summer 2024 To Get Rich

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

GOBankingRates

a year ago

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

Gaming laptops are being left behind

Digital Trends

a year ago

Gaming laptops are being left behind

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

GOBankingRates

a year ago

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

GOBankingRates

a year ago

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

Insider Monkey

a year ago

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

GuruFocus.com

a year ago

Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

Zacks

a year ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

MT Newswires

a year ago

Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

GlobeNewswire

a year ago

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

a year ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

TipRanks

a year ago

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Simply Wall St.

a year ago

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

a year ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

a year ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Simply Wall St.

a year ago

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

GlobeNewswire

a year ago

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19

GlobeNewswire

a year ago

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

GlobeNewswire

a year ago

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

Owning 39% shares,institutional owners seem interested in Taysha Gene Therapies, Inc. (NASDAQ:TSHA),

Simply Wall St.

a year ago

Owning 39% shares,institutional owners seem interested in Taysha Gene Therapies, Inc. (NASDAQ:TSHA),

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

7 Micro-Cap Stocks That Could Majorly Surprise Investors

InvestorPlace

a year ago

7 Micro-Cap Stocks That Could Majorly Surprise Investors

Unitil Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

a year ago

Unitil Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

a year ago

Diana Shipping Inc. Announces Expansion of Previously Announced Joint Venture for Offshore Wind Service Vessels

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

GlobeNewswire

a year ago

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

Cushman & Wakefield plc (CWK) is Benefitting from Secular Trends

Insider Monkey

a year ago

Cushman & Wakefield plc (CWK) is Benefitting from Secular Trends

Private companies account for 54% of Betterware de México, S.A.P.I. de C.V.'s (NASDAQ:BWMX) ownership, while individual investors account for 33%

Simply Wall St.

a year ago

Private companies account for 54% of Betterware de México, S.A.P.I. de C.V.'s (NASDAQ:BWMX) ownership, while individual investors account for 33%

The 7 Most Undervalued Growth Stocks to Buy in January

InvestorPlace

a year ago

The 7 Most Undervalued Growth Stocks to Buy in January

3 Growth Stocks That Could Go Parabolic in 2024

Motley Fool

a year ago

3 Growth Stocks That Could Go Parabolic in 2024

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

GlobeNewswire

a year ago

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 6,009 Shares

GuruFocus.com

a year ago

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 6,009 Shares

Share on Social Networks: